search
Back to results

Effect of a Multi Strain Probiotic on the Gut Microbiota

Primary Purpose

Microbial Colonization

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Fasted breath samples
Daily Diary
Stool sample
Sponsored by
The Functional Gut Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Microbial Colonization focused on measuring Probiotics, Microbiome, Gastrointestinal

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult males and females (50:50) between 18 to 40 years old
  • No significant medical diagnosis (healthy individuals)
  • Not on regular prescription medicines
  • No selective/restricted diets (e.g. vegan, low FODMAP)
  • Body Mass Index of 18.50-29.99 kg/m2
  • Participant able to understand the participant information sheet in English and provide informed consent

Exclusion Criteria:

  • Diagnosis of any medical condition, except for visual impairment and other conditions to clinicians discretion
  • Prior abdominal surgery (e.g. appendectomy, bariatric surgery )
  • Migraine as based on migraine definition by ICHD 2019:

    • A minimum of five attacks (in absolute terms) fulfilling criteria:

      • Duration 4 - 72 hours
      • At least two of the following:
  • unilateral location
  • pulsating character
  • moderate or severe pain intensity
  • aggravation by routine physical activity
  • Presence of nausea/vomiting OR photophobia/phonophobia during headache
  • Ongoing therapy with medication known to affect the gut microbiome:

    • Antibiotics used in the last 8 weeks
    • Proton pump inhibitors used in the last 8 weeks
    • Antidepressants in the last 8 weeks
    • Regular use of laxatives or anti-diarrheal medications
  • Alcohol consumption >14 units per week
  • Pregnancy or breastfeeding
  • Vegan and other selective diets, use of diet replacements (e.g. Huel)
  • Regular consumption of probiotics, prebiotics, fibre supplements or any use of probiotics in 2 months prior enrolment
  • Unwillingness to exclude other probiotic products from diet during the study period

Sites / Locations

  • The Functional Gut Clinic

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

BioKult Advanced

Arm Description

This is a single arm study, all participants will take Bio-kult Advanced for 56 days (+/- 2days). Participants will be required to take 4 capsules daily.

Outcomes

Primary Outcome Measures

Stool sample comparison
Comparison between samples at different taxonomical levels (phylum, family, genus and species) will be performed for the identification of specific bacteria in samples of interest. Accumulative bar charts will be provided for rapid inspection. PCA and clustering will be conducted. Biodiversity Index (Shannon, Simpson, Gini-Simpson or Berger-Parker) will be calculated. Biostatistics will be done in order to detect biomarkers between timepoints of the study.

Secondary Outcome Measures

Fasting breath samples
Mean change in fasted breath hydrogen and methane, will be determined from baseline to end of study. Mean fasted hydrogen and mean fasted methane will be calculated independently of one each other. Breath hydrogen and breath methane will be measured in units of parts per million (ppm). Statistical significance will be determined using a paired t-test (p<0.05).
Bowel habit
Mean difference in stool frequency and consistency from baseline and end of study will be determined using a paired t-test, to determine significance (p<0.05).

Full Information

First Posted
September 4, 2020
Last Updated
February 15, 2021
Sponsor
The Functional Gut Clinic
Collaborators
ADM Protexin
search

1. Study Identification

Unique Protocol Identification Number
NCT04554641
Brief Title
Effect of a Multi Strain Probiotic on the Gut Microbiota
Official Title
The Effect of a Multi-strain Live Bacteria Supplement on the Gut Microbiota Composition of Healthy Adults: an Open Label Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
February 12, 2021 (Actual)
Study Completion Date
February 12, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Functional Gut Clinic
Collaborators
ADM Protexin

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Over recent years there has been a lot of research looking at how the bacteria in our gut affect our health. Changes to gut bacteria has been linked to several diseases. Taking specific live bacteria supplements (sometimes known as 'probiotics'), to change the balance of our gut bacteria to result in a health benefit have been trialled as a treatment option for many diseases in recent years. Bio-Kult Advanced is a live bacteria Food supplement that contains 14 different bacteria cultures. The effect of Bio-Kult Advanced on gut bacteria is unknown, therefore, the aim
Detailed Description
There is rapidly growing interest in the involvement of the microbiome in health. Imbalance in human gut microbiota, 'dysbiosis', has been linked to several diseases. Manipulation of the microbiome, using specific strains of live micro-organisms, that confer a health benefit on the host (probiotics), have therefore become an exploratory treatment option in microbiome-associated diseases in recent years. Numerous studies have shown selected strains of bacteria to show statistically significant and clinically relevant improvement in symptoms, in a number of diseases, including but not limited to infantile colic and atopic dermatitis. Bio-Kult Advanced (BKA) is a 14 strain live bacteria supplement containing a Minimum 2 billion live microorganisms per capsule (2x109 CFU/capsule), equivalent to 10 billion live microorganisms per gram (1x1010 CFU/gram). A randomised controlled trial of Bio-Kult Advanced in the management of diarrhoea predominant IBS demonstrated significant improvement in gastrointestinal (GI) symptoms and was well tolerated by participants. Another randomised controlled trial of Bio-Kult Advanced, in participants with episodic and chronic migraine sufferers, demonstrated significant improvement in frequency and severity of migraines compared to placebo. This clinical effectiveness across various conditions, suggest that bacterial strains in Bio-Kult could have an effect on the gastrointestinal flora, however data has yet to be collected that explores the effect of Bio-Kult on the microbiome. The aim of this study is to therefore investigate the effect of Bio-Kult Advanced, on the composition of the gut microbiota in healthy adults.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Microbial Colonization
Keywords
Probiotics, Microbiome, Gastrointestinal

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
BioKult Advanced
Arm Type
Experimental
Arm Description
This is a single arm study, all participants will take Bio-kult Advanced for 56 days (+/- 2days). Participants will be required to take 4 capsules daily.
Intervention Type
Other
Intervention Name(s)
Fasted breath samples
Intervention Description
Participants will provide fasted breath samples pre and post Bio-Kult Advanced.
Intervention Type
Other
Intervention Name(s)
Daily Diary
Intervention Description
Monitoring stool form, consistency and frequency on a daily basis.
Intervention Type
Other
Intervention Name(s)
Stool sample
Intervention Description
Participants will provide stool sample pre and post Bio-kult Advanced.
Primary Outcome Measure Information:
Title
Stool sample comparison
Description
Comparison between samples at different taxonomical levels (phylum, family, genus and species) will be performed for the identification of specific bacteria in samples of interest. Accumulative bar charts will be provided for rapid inspection. PCA and clustering will be conducted. Biodiversity Index (Shannon, Simpson, Gini-Simpson or Berger-Parker) will be calculated. Biostatistics will be done in order to detect biomarkers between timepoints of the study.
Time Frame
56 days
Secondary Outcome Measure Information:
Title
Fasting breath samples
Description
Mean change in fasted breath hydrogen and methane, will be determined from baseline to end of study. Mean fasted hydrogen and mean fasted methane will be calculated independently of one each other. Breath hydrogen and breath methane will be measured in units of parts per million (ppm). Statistical significance will be determined using a paired t-test (p<0.05).
Time Frame
56 days
Title
Bowel habit
Description
Mean difference in stool frequency and consistency from baseline and end of study will be determined using a paired t-test, to determine significance (p<0.05).
Time Frame
56 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult males and females (50:50) between 18 to 40 years old No significant medical diagnosis (healthy individuals) Not on regular prescription medicines No selective/restricted diets (e.g. vegan, low FODMAP) Body Mass Index of 18.50-29.99 kg/m2 Participant able to understand the participant information sheet in English and provide informed consent Exclusion Criteria: Diagnosis of any medical condition, except for visual impairment and other conditions to clinicians discretion Prior abdominal surgery (e.g. appendectomy, bariatric surgery ) Migraine as based on migraine definition by ICHD 2019: A minimum of five attacks (in absolute terms) fulfilling criteria: Duration 4 - 72 hours At least two of the following: unilateral location pulsating character moderate or severe pain intensity aggravation by routine physical activity Presence of nausea/vomiting OR photophobia/phonophobia during headache Ongoing therapy with medication known to affect the gut microbiome: Antibiotics used in the last 8 weeks Proton pump inhibitors used in the last 8 weeks Antidepressants in the last 8 weeks Regular use of laxatives or anti-diarrheal medications Alcohol consumption >14 units per week Pregnancy or breastfeeding Vegan and other selective diets, use of diet replacements (e.g. Huel) Regular consumption of probiotics, prebiotics, fibre supplements or any use of probiotics in 2 months prior enrolment Unwillingness to exclude other probiotic products from diet during the study period
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anthony Hobson
Organizational Affiliation
The Functional Gut Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Functional Gut Clinic
City
Manchester
ZIP/Postal Code
M2 4NG
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Effect of a Multi Strain Probiotic on the Gut Microbiota

We'll reach out to this number within 24 hrs